Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Bosentan blocks TNFα-induced GM-CSF expression in human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Effects of bosentan, ambrisentan and TBC3711 on TNFα induced and endothelin-1 modulated gm-csf expression in human airway smooth muscle cells Source: Annual Congress 2009 - Airway cell biology Year: 2009
Heme-oxygenase (HO)-1 inhibits TNF-α induced CXCL10 secretion by airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011
Eotaxin/CCL11 inhibits proliferation of human airway smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 127s Year: 2005
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006
Effects of IL-5 and IL-13 on human airway smooth muscle migration, proliferation and cytokine synthesis Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005
Endothelin receptor B (ETB R) dependent GM-CSF mRNA stabilization explains the higher efficacy of bosentan vs. ambrisentan in the reduction of GM-CSF release from human airway smooth muscle cells (HASMCs) Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005
Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011
Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2 Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007
Theophylline at the therapeutic concentrations abrogate decreased smad7 expression in cultured smooth muscle cells stimulated with LTD4 and EGF Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005
Budesonide and formoterol differentially modulate the expression of C/EBP-alpha and calreticulin in airway smooth muscle (ASM) cells Source: Eur Respir J 2006; 28: Suppl. 50, 756s Year: 2006
A comparison of beta2 -adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
Effects of fluticasone and salmeterol on cytokine-induced airway smooth muscle IP10 release Source: Eur Respir J 2005; 26: Suppl. 49, 712s Year: 2005
Resveratrol is superior to dexamethasone in suppressing cytokine release from human airway smooth muscle cells exposed to lipoteichoic acid in COPD Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013